Researchers have created an AI-driven liquid biopsy that scans patterns in fragments of DNA. The system detects early liver fibrosis and cirrhosis — conditions that often go unnoticed.

By analysing genome-wide DNA fragmentation patterns rather than specific mutations, the approach captures signals about a person’s overall health.